PMV PHARMACEUTICALS INC (PMVP:NASDAQ)
$1.52 0.03 (2.0134%)
Analysed PMV PHARMACEUTICALS INC (PMVP:NASDAQ) News Sources
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity
02-06-2026
yahoo.com
PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10-06-2026
yahoo.com
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
14-08-2026
yahoo.com
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
31-08-2026
yahoo.com
PMV Pharma Announces Proposed Public Offering of Securities
31-08-2026
yahoo.com
PMV Pharmaceuticals Reports Updated Rezatapopt Ovarian Cancer Data, Commences Offering
31-08-2026
yahoo.com
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
01-09-2026
yahoo.com
PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push
01-09-2026
yahoo.com
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
08-09-2026
yahoo.com
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
05-10-2026
yahoo.com
What is the current price of PMV PHARMACEUTICALS INC (PMVP:NASDAQ)?
The current price of PMV PHARMACEUTICALS INC (PMVP:NASDAQ) is $1.52.
PMV PHARMACEUTICALS INC (PMVP:NASDAQ) absolute price change since previous trading day?
The absolute price change of PMV PHARMACEUTICALS INC (PMVP:NASDAQ) since the previous trading day is $0.03.
PMV PHARMACEUTICALS INC (PMVP:NASDAQ) percentage price change since previous trading day?
The percentage price change of PMV PHARMACEUTICALS INC (PMVP:NASDAQ) since the previous trading day is 2.0134%.
What is the most recent average sentiment score for PMV PHARMACEUTICALS INC (PMVP:NASDAQ)?
The most recent average sentiment score for PMV PHARMACEUTICALS INC (PMVP:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for PMV PHARMACEUTICALS INC (PMVP:NASDAQ)?
The most recent sentiment for PMV PHARMACEUTICALS INC (PMVP:NASDAQ) is .
SEC-8K** Filing Available For PMV PHARMACEUTICALS INC (PMVP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.